Status:
COMPLETED
Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
Lead Sponsor:
Aswan University Hospital
Conditions:
Erectile Dysfunction
Eligibility:
MALE
35-56 years
Phase:
NA
Brief Summary
Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of ere...
Eligibility Criteria
Inclusion
- patients with type 2 DM
Exclusion
- Patients with history of pelvic trauma, major pelvic surgical intervention, hypogonadism, hyperprolactinemia, hypertension, chronic prostatitis, chronic liver disease, smokers, history of chronic intake of CNS or anti-androgen drugs and patients with Peyronie's Disease or any fibrotic anomalies
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03834610
Start Date
October 1 2017
End Date
October 1 2018
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528